0001104659-23-129185.txt : 20231226
0001104659-23-129185.hdr.sgml : 20231226
20231226160523
ACCESSION NUMBER: 0001104659-23-129185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20231226
DATE AS OF CHANGE: 20231226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rombotis Spiro George
CENTRAL INDEX KEY: 0001357396
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50626
FILM NUMBER: 231513359
MAIL ADDRESS:
STREET 1: C/O CYCLACEL PHARMACEUTICALS, INC.
STREET 2: 200 CONNELL DRIVE, SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER NAME:
FORMER CONFORMED NAME: Rombotis Spiro
DATE OF NAME CHANGE: 20060324
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001130166
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911766850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-7330
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER COMPANY:
FORMER CONFORMED NAME: XCYTE THERAPIES INC
DATE OF NAME CHANGE: 20001218
4
1
tm2333679-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-21
0
0001130166
Cyclacel Pharmaceuticals, Inc.
CYCC
0001357396
Rombotis Spiro George
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS
NJ
07922
1
1
0
0
President and CEO
0
Common Stock
2023-12-21
4
P
0
6070
3.315
A
68658
D
Warrants (right to buy)
3.19
2023-12-21
4
P
0
6070
0
A
2023-12-21
2030-12-21
Common Stock
6070
6070
D
The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.
/s/ Spiro Rombotis
2023-12-26